General Information of This Drug (ID: DMH9NAY)

Drug Name
PAT-001   DMH9NAY
Indication
Disease Entry ICD 11 Status REF
Non-syndromic ichthyosis EC20.0Y Phase 2 [1]
Autosomal recessive congenital ichthyosis EC20.02 Phase 1 [2]

List of Combinatorial Drugs (CBD) Containing This Drug

1 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
PAT-001 + Idarubicin DCG9WE1 Idarubicin Glioblastoma? (Cell Line: T98G) [3]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.